Cost-effectiveness of topical 0.03% flurbiprofen in outpatient cataract surgery as measured by surgical time and vitreous loss.
Gaynes
B I
BI
Department of Ophthalmology, Rush Medical College of Rush University, Chicago, IL 60612, USA. bgaynes@rush.edu
Deutsch
T A
TA
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics* / Q000627:therapeutic use; D002387:Cataract Extraction / Q000191:economics; D002641:Chicago; D002648:Child; D003362:Cost-Benefit Analysis; D005260:Female; D005480:Flurbiprofen / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D007910:Lenses, Intraocular / Q000191:economics; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D015877:Miosis / Q000191:economics / Q000517:prevention & control*; D010044:Outpatient Clinics, Hospital; D018918:Phacoemulsification / Q000191:economics*; D011300:Preoperative Care; D012189:Retrospective Studies; D013997:Time Factors; D014821:Vitrectomy / Q000191:economics*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005480:Flurbiprofen